|
|
|
Volumn 25, Issue 5, 1998, Pages 671-684
|
|
Essential conditions for the development of new anticancer drugs based on ICH-GCP
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CLINICAL TRIAL;
HUMAN;
INFORMED CONSENT;
JAPAN;
NEOPLASM;
QUESTIONNAIRE;
STANDARD;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
HUMANS;
INFORMED CONSENT;
JAPAN;
NEOPLASMS;
QUESTIONNAIRES;
|
|
EID: 0032040174
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
